Dexamethasone pretreatment alleviates intestinal ischemiaereperfusion injury

Journal of Surgical Research

Volumn 185, Issue 2, 2013, Pages 851-860

  Zhang, Wenhua ^a,b   Xing, Jibin ^a   Liu, Dezhao ^a   Gan, Xiaoliang ^a   Gao, Wanling ^a   Heia, Ziqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangzhou Women and Children's Medical Center   (China)

Author keywords

Dexamethasone; Intestine; Ischemiaereperfusion injury; Mast cell

Indexed keywords

DEXAMETHASONE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; GLUCOCORTICOID; PROTEINASE ACTIVATED RECEPTOR 2; TPSAB1 PROTEIN, MOUSE; TRYPTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; ENTERITIS; INTESTINE ISCHEMIA; MAST CELL; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY; SURVIVAL RATE; ACUTE DISEASE; ANIMAL; DISEASE MODEL; DRUG EFFECT; ENTEROPATHY; IMMUNOLOGY; INBRED MOUSE STRAIN; INTESTINE; ISCHEMIA-REPERFUSION INJURY; MALE; METABOLISM; RANDOMIZATION; TIME; DRUG EFFECTS; INTESTINAL DISEASES;

DEXAMETHASONE; INTESTINE; ISCHEMIA-REPERFUSION INJURY; MAST CELL;

ACUTE DISEASE; ANIMALS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; INTESTINAL DISEASES; MALE; MAST CELLS; MICE; MICE, INBRED STRAINS; RANDOM ALLOCATION; RECEPTOR, PAR-2; REPERFUSION INJURY; SURVIVAL RATE; TIME FACTORS; TRYPTASES;

EID: 84891686265     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.07.049     Document Type: Article

References (41)

1. Stefanutti G, Pierro A, Vinardi S, et al. Moderate hypothermia protects against systemic oxidative stress in a rat model of intestinal ischemia and reperfusion injury. Shock 2005;24:159.
2. Schoots IG, Koffeman GI, Legemate DA, et al. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg 2004;91:17.
3. Acosta-Merida MA, Marchena-Gomez J, Hemmersbach-Miller M, et al. Identification of risk factors for perioperative mortality in acute mesenteric ischemia. World J Surg 2006; 30:1579.
4. Bischoff SC, Kramer S. Human mast cells, bacteria, and intestinal immunity. Immunol Rev 2007;217:329.
5. Bischoff SC. Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol 2009;31:185.
6. Klooker TK, Braak B, Koopman KE, et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 2010;59:1213.
7. Andoh A, Fujiyama Y, Araki Y, et al. Role of complement activation and mast cell degranulation in the pathogenesis of rapid intestinal ischemia/reperfusion injury in rats. Digestion 2001;63(Suppl 1):103.
8. Hei ZQ, Gan XL, Huang PJ, et al. Influence of ketotifen, cromolyn sodium, and compound 48/80 on the survival rates after intestinal ischemia reperfusion injury in rats. BMC Gastroenterol 2008;8:42.
9. Kalia N, Brown NJ, Wood RF, et al. Ketotifen abrogates local and systemic consequences of rat intestinal ischemia-reperfusion injury. J Gastroenterol Hepatol 2005;20:1032.
10. Tokudome S, Sano M, Shinmura K, et al. Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. J Clin Invest 2009;119:1477.
11. Felszeghy K, Banisadr G, Rostene W, et al. Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia- induced brain injury in neonatal rats. Neuroimmunomodulation 2004;11:404.
12. Feng Y, Rhodes PG, Bhatt AJ. Dexamethasone pre-treatment protects brain against hypoxic-ischemic injury partially through up-regulation of vascular endothelial growth factor A in neonatal rats. Neuroscience 2011;179:223.
13. Kumar S, Allen DA, Kieswich JE, et al. Dexamethasone ameliorates renal ischemia-reperfusion injury. J Am Soc Nephrol 2009;20:2412.
14. Chatterjee S, Premachandran S, Shukla J, et al. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock. J Surg Res 2007;140:99.
15. Vieira AT, Pinho V, Lepsch LB, et al. Mechanisms of the anti-inflammatory effects of the natural secosteroids physalins in a model of intestinal ischaemia and reperfusion injury. Br J Pharmacol 2005;146:244.
16. Shin K, Nigrovic PA, Crish J, et al. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol 2009;182:647.
17. Kim SI, Kim YB, Koh KM, et al. Activation of NF-kb pathway in oral buccal mucosa during small intestinal ischemia-reperfusion injury. J Surg Res 2013;179:99.
18. Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 1970; 101:478.
19. Abraham E, Carmody A, Shenkar R, et al. Neutrophils as early immunologic effectors in hemorrhage-or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2000;279:L1137.
20. Abraham E, Kaneko DJ, Shenkar R. Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation. Am J Physiol 1999;276:L1.
21. Tang C, Lan C, Wang C, et al. Amelioration of the development of multiple organ dysfunction syndrome by somatostatin via suppression of intestinal mucosal mast cells. Shock 2005;23:470.
22. He SH. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 2004;10:309.
23. Castells MC, Irani AM, Schwartz LB. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol 1987;138:2184.
24. Huygen FJ, Ramdhani N, van Toorenenbergen A, et al. Mast cells are involved in inflammatory reactions during complex regional pain syndrome type 1. Immunol Lett 2004; 91:147.
25. Yamamoto S, Tanabe M, Wakabayashi G, et al. The role of tumor necrosis factor-alpha and interleukin-1beta in ischemia-reperfusion injury of the rat small intestine. J Surg Res 2001;99:134.
26. Szabo A, Boros M, Kaszaki J, et al. The role of mast cells in mucosal permeability changes during ischemia-reperfusion injury of the small intestine. Shock 1997;8:284.
27. Samtani MN, Jusko WJ. Comparison of dexamethasone pharmacokinetics in female rats after intravenous and intramuscular administration. Biopharm Drug Dispos 2005; 26:85.
28. Boros M, Ordogh B, Kaszaki J, et al. The role of mast cell degranulation in ischaemia-reperfusion-induced mucosal injury in the small intestine. Ann Acad Med Singapore 1999; 28:79.
29. Jiang W, Kirkup AJ, Grundy D. Mast cells drive mesenteric afferent signalling during acute intestinal ischaemia. J Physiol 2011;589:3867.
30. McNeil HP, Reynolds DS, Schiller V, et al. Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7. Proc Natl Acad Sci USA 1992;89:11174.
31. Funaba M, Ikeda T, Murakami M, et al. Transcriptional activation of mouse mast cell protease-7 by activin and transforming growth factor-beta is inhibited by microphthalmia-associated transcription factor. J Biol Chem 2003;278:52032.
32. Okayama Y, Kawakami T. Development, migration, and survival of mast cells. Immunol Res 2006;34:97.
33. Caughey GH. Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 2007;217:141.
34. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 2010;10:440.
35. Nosal'ova V, Drabikova K, Jancinova V, et al. Effect of H1 antihistamines in a model of mesenteric ischaemia/reperfusion. Inflamm Res 2008;57(Suppl 1):S55.
36. Gan X, Liu D, Huang P, et al. Mast-cell-releasing tryptase triggers acute lung injury induced by small intestinal ischemia-reperfusion by activating Par-2 in rats. Inflammation; 2011.
37. Kawabata A, Kuroda R. Protease-activated receptor (PAR), a novel family of G protein-coupled seven trans-membrane domain receptors: activation mechanisms and physiological roles. Jpn J Pharmacol 2000;82:171.
38. Berger P, Perng DW, Thabrew H, et al. Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. J Appl Physiol 2001;91: 1372.
39. Compton SJ, Cairns JA, Holgate ST, et al. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J Immunol 1998; 161:1939.
40. Yoshida N, Takagi T, Isozaki Y, et al. Proinflammatory role of protease-activated receptor-2 in intestinal ischemia/reperfusion injury in rats. Mol Med Rep 2011;4:81.
41. Yao YM, Bahrami S, Redl H, et al. Monoclonal antibody to tumor necrosis factor-alpha attenuates hemodynamic dysfunction secondary to intestinal ischemia/reperfusion in rats. Crit Care Med 1996;24:1547.